glp 1 medication interactions GLP‐1 Agonists for Pediatric Psychopharmacology: Opportunities and Cautions GLP-1 Interactions - Endocrinology Advisor

The intestines are the second biggest organ that uses glucose, following the brain

E N D Presentation Transcript L-Carnitine Charisma Garcia NFSC 345 Introduction Background Purported Benefits Mechanism of Action Evidence of Benefits Conflicting Research Safety Concerns Professional Position L-Carnitine Essential for Energy Production Naturally Occurs in the Human Body Synthesized in the Liver & Kidneys Derived from the amino acid, Lysine Produces 11-34mg/day (Sufficient to meet all needs!) Dietary L-Carnitine Red meat, dairy, fish, wheat, asparagus, avocado Omnivorous diet: 20-200mg/day (~75% absorbed) No proof of Dietary need exists L-Carnitine as a Supplement Liquid form,Tablets & Capsules Typical Dose: 1000-6000 mg/day ~20% absorbed by the body Generally non-toxic Intended population: Athletes Dieters Purported Benefits Primary Systemic Carnitine Deficiency A recessive gene mutation Cardiovascular Disease Alzheimers Disease Chronic Fatigue In the Elderly Population In Cancer Patients Fat Loss No Evidence EXERCISE PERFORMANCE

We found that NAC reduced the cell index compared to the untreated group, consistent with our previous findings 20

However, certain conditions require careful provider evaluation or may contraindicate use entirely

Both HFDs markedly impaired glucose tolerance (ESM Fig

Edaravone-MIL-53(Cr) nanoparticles alleviated brain injury and cognitive dysfunction in mice receiving whole-brain irradiation (Li et al., 2025)